Cite
Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine.
MLA
Ashina, Messoud, et al. “Reduction in the Severity and Duration of Headache Following Fremanezumab Treatment in Patients with Episodic and Chronic Migraine.” Headache: The Journal of Head & Face Pain, vol. 61, no. 6, June 2021, pp. 916–26. EBSCOhost, https://doi.org/10.1111/head.14127.
APA
Ashina, M., Cohen, J. M., Gandhi, S. K., & Du, E. (2021). Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine. Headache: The Journal of Head & Face Pain, 61(6), 916–926. https://doi.org/10.1111/head.14127
Chicago
Ashina, Messoud, Joshua M. Cohen, Sanjay K. Gandhi, and Evelyn Du. 2021. “Reduction in the Severity and Duration of Headache Following Fremanezumab Treatment in Patients with Episodic and Chronic Migraine.” Headache: The Journal of Head & Face Pain 61 (6): 916–26. doi:10.1111/head.14127.